Dissecting the Heterogeneity of Human Thoracic Aortic Aneurysms Using Single-Cell Transcriptomics

Area of Science:

• Cardiovascular Biology
• Genomics
• Translational Medicine

Background:

• Thoracic aortic aneurysm (TAA) is a dangerous condition where the aorta wall weakens, often leading to rupture or dissection.
• Current treatments for TAA are limited, with surgery being the only effective option, highlighting the need for new therapeutic strategies.
• Understanding the cellular diversity within the human aortic wall is crucial for unraveling TAA pathogenesis.

Purpose of the Study:

• To review recent advances in single-cell RNA sequencing (scRNA-seq) for studying thoracic aortic aneurysm (TAA).
• To discuss the application of scRNA-seq and related technologies in TAA research.
• To identify challenges and future directions for using high-content technologies in TAA studies.

Main Methods:

• Review of current literature on single-cell RNA sequencing studies of aortic cell populations.
• Analysis of findings from in vivo and in vitro studies of thoracic aortic aneurysm (TAA) and dissection.
• Discussion of the utility of transcriptomics and high-content technologies in TAA research.

Main Results:

• Single-cell RNA sequencing is revealing the complex cellular heterogeneity within the human aorta.
• Recent studies have begun to dissect the cellular complexity underlying thoracic aortic aneurysm (TAA) and dissection.
• Valuable insights into TAA pathogenesis are emerging from scRNA-seq analyses of aortic tissues.

Conclusions:

• Single-cell transcriptomics provides a powerful approach to investigate thoracic aortic aneurysm (TAA) heterogeneity.
• Further application of these technologies is essential for developing novel therapeutic strategies for TAA.
• Addressing the challenges in scRNA-seq data analysis and interpretation will accelerate TAA research.